Pediatric skin cancer is rare but devastating, and standard cancer therapies are associated with both short- and long-term consequences. PeDRA’s STARC Working Group works tirelessly to refine our understanding of primary skin tumors, to generate longitudinal data on the natural history and outcomes of potential precursors of skin malignancy, and to define and address unmet needs in cutaneous complications from therapies.
The STARC Working Group is chaired by Carrie Coughlin, MD of Washington University, Jen Huang, MD of Harvard Medical School, and Larry Eichenfield, MD of the University of California, San Diego. Contact us if you’re interested in getting involved!
Stay up to date
As research and studies increase in our STARC Working Group, stay informed of relevant updates through a quarterly e-newsletter